Brief: Conmed Q3 Adjusted EPS USD 1.05 Vs. IBES Estimate USD 0.99
30/10/2024 20:05
Oct 30 (Reuters) - Conmed Q3 sales USD 316.701 million vs. IBES estimate USD 318.1 million. * Q3 income from operations USD 65.707 million vs. IBES estimate USD 48.9 million * Q3 pretax profit USD 56.455 million vs. IBES estimate USD 39.6 million * Q3 EPS USD 1.57 * Q3 net income USD 48.984 million * outlook FY adjusted EPS USD 4-4.05
Recent news on Conmed
See all newsU.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Conmed Corp reports results for the quarter ended June 30 - Earnings Summary
Conmed Q2 sales, adjusted profit beat on organinc platform growth
Brief: Conmed Q2 Adjusted EPS USD 1.38 Vs. IBES Estimate USD 1.11
Brief: Conmed Is Said To Weigh Sale After Takeover Interest- Bloomberg News